Tome Biosciences is based in Watertown, Massachusetts. It has raised $213M in total funding. Latest round: Series B.
Tome Biosciences is based in Watertown, Massachusetts. Tome Biosciences has raised $213M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in July 2025. The round record for Tome Biosciences runs through 2025; nothing later has been disclosed. Investors on record include Andreessen Horowitz (a16z) Bio + Health, Arch Venture Partners, GV, Longwood Fund, Polaris Partners, Bruker Corporation and 2 others. 8 distinct backers are named across the disclosed rounds.
We update the Tome Biosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Watertown and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026